"HI-Bio was really the key catalyst to bring us back to California," a Biogen executive said of its new South San Francisco ...

Company promotes Zubin Meshginpoosh to Chief Executive Officer and President to Drive Next Phase of ExpansionSAN DIEGO, April ...

Derayah Financial Co., manager of Derayah REIT Fund, said it was notified by its legal counsel of a final ruling dismissing a ...

Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage ...

AN ingredient found in cheap veg could help banish agonising period pain, scientists say. L-ergothioneine is an antioxidant – ...

Xtalks is pleased to announce its role as an official Media Partner for the Toronto Life Sciences and Biotech Summit, taking ...

Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs for the treatment of orphan oncology ...

A memorandum of understanding for the initiative was signed between the state government's department of science and technology and the National Centre for Coastal Research under the Ministry of Earth ...

To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on ...

US startup Bond Pet Foods has welcomed Germany's Symrise as an investor, with the firms partnering to create new ...

Brenig Therapeutics Inc. (Brenig), a clinical-stage biotechnology company developing brain-penetrant small molecule therapies for neurodegenerative diseases, today announced that data from its ongoing ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...